Tinnitus and other dysacuses

Scott-Brown's Otorhinolaryngology: Head and Neck Surgery

Volumn , Issue , 2008, Pages 3594-3628

  Ceranic, Borka ^a   Luxon, Linda M ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85051769820     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (285)

1. Feldmann H. History of tinnitus research. In: Shulman A (ed.). Tinnitus: diagnosis/treatment. Philadelphia: Lea and Febiger, 1991: 3-37.
2. Stephens D. A history of tinnitus. In: Tyler R (ed.). Tinnitus handbook. San Diego: Singular Publishing Group, 2000: 437-48.
3. Stephens SDG. Historical aspects of tinnitus. In: Hazell JWP (ed.). Tinnitus. Edinburgh London, Melbourne and New York: Churchill Livingstone, 1987: 1-19.
4. Stephens SDG. The treatment of tinnitus - A historical perspective. Journal of Laryngology and Otology. 1984; 98: 963-72.
5. Feldmann H. Tinnitus in the arts and sciences. In: Feldmann H (ed.). Proceedings of the III International Tinnitus Seminar, Munster. Karlsruhe: Harsch Verlag, 1987: 25-36.
6. Hinchcliffe R. Aspects of paracuses. In: Luxon L, Furman J, Martini A, Stephens SDG (eds). Textbook of audiological medicine. London: Martin Dunitz, 2003: 271-87.
7. Clement-Evans C. New developments in noise-induced hearing loss. ENT News. 1998; 7: 28-9.
8. Hazell JWP. Models of tinnitus: Generation, perception, clinical implications. In: Vernon JA, Møller AR (eds). Mechanisms of tinnitus. Needham Heights, MA: Allyn and Bacon, 1995: 57-72.
9. Jastreboff PJ. Phantom auditory perception (tinnitus): Mechanisms of generation and perception. Neuroscience Research. 1990; 8: 221-54.
10. Fowler EP. Subjective head noises (tinnitus aurium): Genesis and differential, diagnostic significance. A few facts and several speculations. Laryngoscope. 1965; 75: 1610-8.
11. Kemp DT. Physiologically active cochlear micromechanisms - one source of tinnitus. In: Evered D, Lawrenson G (eds). Tinnitus. CIBA Foundation Symposium 85. London: Pitman Books Ltd, 1981: 54-81.
12. Probst R, Lonsbury-Martin BL, Martin GK. A review of otoacoustic emissions. Journal of the Acoustical Society of America. 1991; 89: 2027-67.
13. Penfield W, Rasmussen T. The cerebral cortex of man. New York: MacMillan, 1950.
14. Adams RD, Victor M. Time to understand. A case study of word deafness with reference to the role of time in auditory comprehension. Brain. 1981; 97: 373-84.
15. Shergill SS, Cameron LA, Brammer MJ, Williams SC, Murray RM, McGuire PK. Modality specific neural correlates of auditory and somatic hallucinations. Journal of Neurology. 2001; 71: 688-90.
16. Hunter MD, Griffiths TD, Farrow TF, Zheng Y, Wilkinson ID, Hegde N et al. A neural basis for the perception of voices in external auditory space. Brain. 2003; 126: 161-9.
17. Brandy WT, Lynn JM. Audiological findings in hyperacusis and non-hyperacusis subjects. American Journal of Audiology. 1995; 4: 46-51.
18. Andersson G, Lindvall N, Hursti T, Carlbring P. Hypersensitivity to sound (hyperacusis): A prevalence study conducted via the internet and post. International Journal of Audiology. 2002; 41: 545-54.
19. Jastreboff PJ, Gray WC, Gold SL. Neurophysiological approach to tinnitus patients. American Journal of Otology. 1996; 17: 236-40.
20. Dauman R, Bouscau-Faure F. Assessment and amelioration of hyperacusis in tinnitus patients. Acta Otolaryngologica. 2005; 125: 503-9.
21. Anari M, Axelsson A, Eliasson A, Magnusson L. Hypersensitivity to sound - questionnaire data, audiometry and classification. Scandinavian Audiology. 1999; 28: 219-30.
22. Hinchcliffe R, Chambers C. Loudness of tinnitus: An approach to measurement. Advances in Otorhinolaryngology. 1983; 29: 163-73.
23. Gavilan C, Gavilan J, Rashad M, Gavilan M. Discriminant analysis and in predicting prognosis of Bell's palsy. Acta Otolaryngologica. 1988; 106: 276-80.
24. Wayman D, Pham H, Byl F, Adour K. Audiological manifestations of Ramsay Hunt syndrome. Journal of Laryngology and Otology. 1990; 104: 104-8.
25. McCandless GA, Georing DM. Changes in loudness after stapedectomy. Archives of Otolaryngology. 1974; 100: 344-50.
26. Morioka WT, Neff PA, Boisseranc TE, Hartman PW, Cantrell RW. Audiometric findings in myasthenia gravis. Archives of Otolaryngology. 1976; 102: 211-3.
27. Ceranic B, Prasher DK, Raglan E, Luxon LM. Tinnitus following head injury: Evidence from otoacoustic emissions. Journal of Neurology, Neurosurgery and Psychiatry. 1998; 65: 523-9.
28. Lader M. Anxyiolytic drugs: Dependence, addiction and abuse. European Journal of Neuropsychopharmacology. 1994; 4: 85-91.
29. Marriage J, Barnes N. Is central hyperacusis a symptom of 5-hydroxytryptamine (5-HT) dysfunction? Journal of Laryngology and Otology. 1995; 109: 915-21.
30. Klein AJ, Armstrong BL, Greer M, Brown FR. Hyperacusis and otitis media in individuals with Williams syndrome. Journal of Speech and Hearing Disorders. 1990; 55: 339-44.
31. Levitin DJ, Menon V, Schmitt JE, Eliez S, White CD, Glover GH et al. Neural correlates of auditory perception in Williams syndrome: An fMRI study. Neuroimage. 2003; 18: 74-82.
32. Fukaya T, Nomura Y. Audiological aspects of idiopathic perilymphatic fistula. Acta Otolaryngologica. 1988; Suppl 456: 68-73.
33. Brown M. Impediment of basilar membrane motion reduces overload protection but not threshold sensitivity: Evidence from clinical and experimental hydrops. Hearing Research. 1995; 97: 1-10.
34. Sand T, Vingen V. Visual, long-latency auditory and brainstem auditory evoked potentials in migraine: Relation to pattern size, stimulus intensity, sound and light discomfort thresholds and pre-attack state. Cephalalgia. 2000; 20: 804-20.
35. Carman JS. Imipramine in hyperacusic depression. American Journal of Psychiatry. 1973; 130: 937.
36. Weber H, Pfadenhauer K, Stohr M, Rosier A. Central hyperacusis with phonophobia in multiple sclerosis. Multiple Sclerosis. 2002; 8: 505-9.
37. Axelsson A, Hamernik R. Acute acoustic trauma. Acta Otolaryngologica. 1987; 104: 225-33.
38. Szczepniak WS, Møller AR. Effects of baclofen, clonazepam and diazepam on tone exposure-induced hyperexcitability of the inferior colliculus in rat: Possible therapeutic implications for pharmacological management of tinnitus and hyperacusis. Hearing Research. 1996; 97: 46-53.
39. Coles RRA. Chapter 18: Tinnitus. In: Stephens D (ed.). Scott-Brown's Otolaryngology, Volume 2. Adult audiology, 6th edn. London: Butterworth-Heinemann, 1997: 1-34.
40. Jastreboff PJ, Jastreboff MM. Tinnitus retraining therapy (TRT) as a method for treatment of tinnitus and hyperacusis. Journal of the American Academy of Audiology. 2000; 11: 162-77.
41. Vernon JA, Meikle MB. Tinitus masking. In: Tyler R (ed.). Tinnitus handbook. San Diego: Singular, 2000: 313-76.
42. Sammeth CA, Preves DA, Brandy WT. Hyperacusis: Case studies and evaluation of electronic loudness suppression devices as a treatment approach. Scandinavian Audiology. 2000; 29: 28-36.
43. Tanaka Y, Kamo T, Yoshida M, Yamadori A. So-called cortical deafness. Brain. 1991; 114: 2385-401.
44. Ghosh P. Central diplacusis. European Archives of Otorhinolaryngology. 1990; 247: 48-50.
45. Menon V, Levitin DJ, Smith BK, Lembke A, Krasnow BD, Glazer D et al. Neural correlates of timbre change in harmonic sounds. Neuroimage. 2002; 17: 1742-54.
46. Long G. Perceptual consequences of the interaction between spontaneous otoacoustic emissions and external sounds. Hearing Research. 1998; 119: 49-60.
47. Flottorp G. Pure-tone tinnitus evoked by acoustic stimulation: Idiophonic effect. Acta Otolaryngologica. 1953; 43: 395-415.
48. Ward WD. Tonal monoaural diplacusis. Journal of the Acoustical Society of America. 1955; 27: 365-72.
49. Zurek PM. Spontaneous narrowband acoustic signals emitted from human ears. Journal of the Acoustical Society of America. 1981; 69: 514-23.
50. Klingon GH, Bontecou DC. Localisation in auditory space. Neurology. 1966; 16: 87-886.
51. Soroker N, Calamaro N, Glicksohn J, Myslobodski MS. Auditory inattention in right hemisphere-damaged patients with and without visual neglect. Neuropsychologia. 1997; 35: 249-56.
52. Griffiths TD, Elliot C, Coulthard A, Cartlidge EF, Green GR. A distinct low-level mechanism for interaural timing analysis in human hearing. NeuroReport. 1998; 9: 3383-6.
53. van der Poel JC, Jones SJ, Miller DH. Sound localisation, brainstem auditory evoked potentials and magnetic resonance imaging in multiple sclerosis. Brain. 1988; 111: 1453-74.
54. Olsen WO, Noffsinger D, Carhart R. Masking level differences encountered in clinical population. Audiology. 1976; 15: 287-301.
55. Heller MF, Bergmann M. Tinnitus in normally hearing persons. Annals of Otology, Rhinology, and Laryngology. 1953; 62: 73-83.
56. Coles RRA. Epidemiology of tinnitus: (1) Prevalence and (2) Demographic and clinical features. Journal of Laryngology and Otology Supplement. 1984; 9: 7-15, 195-202.
57. Axelsson B, Ringdahl A. The occurrence and severity of tinnitus. In: Feldmann H (ed.). Proceedings of the III International Tinnitus Seminar, Münster. Karlsruhe: Harsch Verlag, 1987: 154-8.
58. Quaranta A, Assennato G, Sallustio V. Epidemiology of hearing problems among adults in Italy. Scandinavian Audiology. 1996; Suppl 42: 9-13.
59. National Center for Health Statistics. Hearing status and ear examination: Findings among adults. United States, 1960-1962. Vital and Health Statistics, Series 11, No. 32, US Department of HEW, Washington DC, November 1968.
60. Cooper Jr. JC. Tinnitus, subjective hearing loss and wellbeing. Health and Nutrition Examination Survey of 1971-75: Part II. Journal of the American Academy of Audiology. 1994; 5: 37-43.
61. Davies A, Rafaie EA. Epidemiology of tinnitus. In: Tyler R (ed.). Tinnitus handbook. San Diego: Singular, 2000: 1-23.
62. Smith P, Coles R. Epidemiology of tinnitus: An update. In: Feldmann H (ed.). Proceedings of the III International Tinnitus Seminar, Muünster. Karlsruhe: Harsch Verlag, 1987: 147-53.
63. Andersson G, McKenna L. Tinnitus masking and depression. Audiology. 1998; 37: 174-82.
64. Attias J, Shemes Z, Bleich A, Solomon Z, Bar-Or G, Alster J et al. Psychological profile of help-seeking and non-help-seeking tinnitus patients. Scandinavian Audiology. 1995; 24: 13-8.
65. Newman CW, Wharton JA, Jacobson GP. Self-focused and somatic attention in patients with tinnitus. Journal of the American Academy of Audiology. 1997; 8: 143-9.
66. Fowler EF. Tinnitus aurium: Its significance in certain diseases of the ear. New York State Journal of Medicine. 1912; 12: 702-4.
67. Cawthorne TE. Otosclerosis. Journal of Laryngology and Otology. 1955; 69: 437-56.
68. Ramsden RT. Acoustic tumours. In: Kerr AG (ed.). Scott-Brown's Otolaryngology, 5th edn. Vol 3. Otology, Chapter 21. London: Butterworths, 1987.
69. Daugherty WT, Lederman RJ, Nodar RH, Conomy JP. Hearing loss in multiple sclerosis. Archives of Neurology. 1983; 40: 33-5.
70. Medical Research Council's Institute of Hearing Research. Epidemiology of tinnitus. In: Evered D, Lawrenson G (eds). Tinnitus. Ciba Foundation Symposium 85. London: Pitman Books, 1981: 16-34.
71. Coles RR, Davis A, Smith O. Tinnitus: Its epidemiology and management. In: Jensen JH (ed.). Proceedings of the XIV Danavox Symposium. Copenhagen: Danavox Jubilee Foundation, 1990: 377-402.
72. Collet L, Moussu M, Disant F, Ahami T, Morgon A. Minnesota Multiphasic personality inventory in tinnitus disorders. Audiology. 1990; 29: 101-6.
73. Tyler RS, Kelsay D. Advantages and disadvanteges reported by some of the better cochlear-implant patients. American Journal of Otology. 1990; 11: 282-9.
74. Tota G, Bocci G. The importance of the colour of the iris in the evolution of resistance to auditory fatigue. Rivista Oto-Neuro-Oftalmologica. 1967; 43: 183-92.
75. Coles RRA, David AC, Haggard MP. Epidemiology of tinnitus. In: Evered D, Lawrenson G (eds). Tinnitus. Ciba Foundation Symposium 85. London: Pitman Books Ltd, 1981: 16-34.
76. Meilke M, Walsh ET. Characteristics of tinnitus and related observations in over 1,800 tinnitus clinic patients: Proceedings of the 2nd International Tinnitus Seminar, Amsterdam. Journal of Laryngology and Otology, Supplement. 1984; 9: 17-21.
77. Hazell JWP, Wood SM, Cooper HR, Stephens SDG, Corcoran AL, Coles RRA et al. A clinical study of tinnitus maskers. British Journal of Audiology. 1985; 19: 65-146.
78. Alberti PW. Tinnitus in occupational hearing loss: Nosological aspects. Journal of Otolaryngology. 1987; 16: 34-5.
79. Shulman A. Introduction: Definition and classification of tinnitus. In: Kitahara M (ed.). Tinnitus: pathophysiology and management. Tokyo: Igaku-Shoin, 1988: 1-6.
80. Axelsson A. Causes of tinnitus. In: Aran JM, Dauman R (eds). Tinnitus 91. Proceedings of the IV International Tinnitus Seminar, Bordeaux. Amsterdam/New York: Kugler Publications, 1992: 275-7.
81. Nicolas-Puel C, Faulconbrodge RL, Guitton M, Puel J-L, Mondain M, Uziel A. Characteristics of tinnitus and etiology of associated hearing loss: a study of 123 patients. International Tinnitus Journal. 2002; 8: 37-44.
82. Tonndorf J. Acute cochlear disorders; the combination of hearing loss, recruitment, poor speech discrimination and tinnitus. Annals of Otology, Rhinology, and Laryngology. 1980; 89: 353-8.
83. McFadden D. Tinnitus facts, theories and treatments. Washington DC: National Academy Press, 1982.
84. Lenarz T, Schreiner C, Snyder RL, Ernst A. Neural mechanisms of tinnitus. European Archives of Otorhinolaryngology. 1993; 249: 441-6.
85. Coles RRA. Epidemiology, aetiology and classification. In: Reich GE, Vernon JA (eds). Proceedings of the V International Tinnitus Seminar 1995. Portland, OR: American Tinnitus Association, 1996: 25-9.
86. Spoendlin H. Neural connections of the outer hair cell system. Acta Otolaryngologica. 1979; 87: 381-7.
87. Halla JT, Hardin JG. Salicylate ototoxicity in patients with rheumatoid arthritis: A controlled study. Annals of the Rheumatic Diseases. 1988; 47: 134-7.
88. Oudot J, Pignat JC, Martin H. Acute aspirin poisoning and deafness. Journal Francais d'Oto-Rhino-Laryngologie, Audiophonologie, Chirurgie Maxillo-Faciale. 1979; 28: 687-93.
89. Cazals Y. Auditory sensori-neural alterations induced by salicylate. Progress in Neurobiology. 2000; 62: 583-631.
90. Puel JL, Bobbin RP, Fallon M. Salicylate, mefenamate, meclofemamate and quinine on cochlear potentials. Otolaryngology and Head and Neck Surgery. 1990; 1: 66-73.
91. Mammano F, Ashmore JF. Reverse transduction measured in the isolated cochlea by laser Michelson interferometry. Nature. 1993; 365: 838-41.
92. McFadden D, Plattsmier HS. Aspirin abolishes spontaneous otoacoustic emissions. Journal of the Acoustical Society of America. 1984; 76: 443-8.
93. Baskill JL, Coles RA. Pharmacological suppressive treatment for SOAE-tinnitus. In: Reich GE, Vernon JA (eds). Proceedings of the V International Tinnitus Seminar 1995. Portland, OR: American Tinnitus Association, 1996: 195-9.
94. McFadden D, Pasanen EG. Otoacoustic emissions and quinine sulfate. Journal of the Acoustical Society of America. 1994; 95: 3460-74.
95. Guitton MJ, Caston J, Ruel J, Johnson RM, Pujol R, Puel JL. Salicylate induces tinnitus through activation of cochlear NMDA receptors. Journal of Neuroscience. 2003; 23: 3944-52.
96. Seligmann H, Podoshin L, Ben-David J, Fradis M, Goldsher M. Drug-induced tinnitus and other hearing disorders. Drug Safety. 1996; 14: 198-212.
97. Sismanis A. Pulsatile tinnitus: A 15-year experience. American Journal of Otology. 1998; 19: 472-7.
98. Ator GA, Lambert PR, Canalis RF. Tinnitus. In: Canalis RF, Lambert PR (eds). The ear: comprehensive otology. Philadelphia: Lippincott Williams & Wilkins, 2000: 559-70.
99. Møller MB, Møller AR, Jennetta PJ, Hae DJ. Vascular decompression surgery for severe tinnitus: selection criteria and results. Laryngoscope. 1993; 103: 421-7.
100. Møller AR. Vascular compression of cranial nerves II: pathophysiology. Neurological Research. 1999; 21: 439-43.
101. Makins AE, Nikolopoulos TP, Ludman C, O'Donoghue GM. Is there correlation between vascular loops and unilateral auditory symptoms? Laryngoscope. 1998; 108: 1739-42.
102. Badia L, Parikh A, Brookes GB. Management of middle ear myoclonus. Journal of Laryngology and Otology. 1994; 108: 380-2.
103. Dyer RK, McElveen JT. The patulous Eustachian tube: Management options. Otolaryngology and Head and Neck Surgery. 1991; 105: 832-5.
104. Fritsch MH, Wynne MK, Matt BH, Smith WL, Smith CM. Objective tinnitus in children. Otology and Neurotology. 2001; 22: 644-9.
105. Kemp DT. Evidence of mechanical nonlinearity and frequency selective wave amplification in the cochlea. Archives of Otolaryngology. 1979; 224: 37-45.
106. Weissman JL, Hirsch BE. Imaging of tinnitus: A review. Radiology. 2000; 216: 342-9.
107. East CA, Hazell JWP. The suppression of palatal and (or intratympanic) myoclonus by tinnitus masking devices: a preliminary report. Journal of Otology and Laryngology. 1987; 101: 1230-4.
108. Gil-Loyzaga P, Bartolome V, Vicente-Torres A, Carricondo F. Serotonergic innervation of the organ of Corti. Acta Otolaryngologica. 2000; 120: 128-32.
109. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G. Auditory-evoked potentials as indicator of brain serotonergic activity - First evidence in behaving cats. Biological Psychiatry. 1997; 41: 1181-95.
110. Huffman RF, Henson Jr. OW. The descending auditory pathway and acousticomotor system: connections with the inferior colliculus. Brain Research. Brain Research Reviews. 1990; 15: 295-323.
111. Adams JC. Crossed and descending projections to the inferior colliculus. Neuroscience Letters. 1980; 19: 1-5.
112. LeDoux JE, Sakaguchi A, Reis DJ. Subcortical efferent projections of the medial geniculate nucleus mediate emotional responses conditioned to acoustic stimuli. Journal of Neuroscience. 1983; 4: 683-98.
113. Hallam RS, Rachman S, Hinchcliffe R. Psychological aspects of tinnitus. In: Rachman S (ed.). Contribution to medical psychology, Vol 3. Oxford: Pergamon Press, 1984: 31-4.
114. Tyler RS, Baker LJ. Difficulties experienced by tinnitus sufferers. Journal of Speech and Hearing Disorders. 1983; 48: 150-4.
115. Lucas JH, Siegel J. Cortical mechanisms that augment or reduce evoked potentials in cats. Science. 1977; 198: 73-5.
116. Lockwood AH, Salvi RJ, Coad ML, Towsley ML, Wack DS, Murphy BW. The functional neuroanatomy of tinnitus: Evidence from limbic system links and neuronal plasticity. Neurology. 1998; 50: 114-20.
117. Lockwood AH, Salvi RJ, Burkard RF. Tinnitus. New England Journal of Medicine. 2002; 347: 904-10.
118. Levine RA. Somatic (craniocervical) tinnitus and the dorsal cochlear nucleus hypothesis. American Journal of Otology. 1999; 20: 351-62.
119. Shulman A, Strashun AM, Afriyie M, Aronson F, Abel W, Goldstein B. SPECT imaging of brain and tinnitus -neurotologic/neurologic implications. International Tinnitus Journal. 1995; 1: 13-29.
120. Lockwood AH, Salvi RJ, Burkard RF, Galantowicz PJ, Coad ML, Wack DS. Neuroanatomy of tinnitus. Scandinavian Audiology. 1999; Suppl 51: 47-52.
121. Reyes SA, Salvi RJ, Burkard RF, Coad ML, Wack DS, Galantowocz PJ et al. Brain imaging of the effects of lidocaine on tinnitus. Hearing Research. 2002; 171: 43-50.
122. Ceranic JB, Prasher DK, Luxon LM. Tinnitus and otoacoustic emissions. Clinical Otolaryngology. 1995; 20: 192-200.
123. Penner MJ. An estimate of the prevalence of tinnitus caused by spontaneous otoacoustic emissions. Archives of Otolaryngology - Head and Neck Surgery. 1990; 116: 418-23.
124. Penner MJ, Coles RR. Indication for aspirin as a palliative for tinnitus caused by spontaneous acoustic emissions: A case study. British Journal of Audiology. 1992; 26: 92-6.
125. Mott JB, Norton SJ, Neely ST, Warr WB. Changes in spontaneous otoacoustic emissions produced by acoustic stimulation on the contralteral ear. Hearing Research. 1989; 38: 229-42.
126. Harrison WA, Burns EM. Effects of contralateral acoustic stimulation on spontaneous otoacoustic emissions. Journal of the Acoustical Society of America. 1993; 94: 2649-58.
127. Duchamp C, Morgon A, Chery-Croze S. Tinnitus sufferers without hearing loss. In: Reich GE, Vernon JA (eds). Proceedings of the V International Tinnitus Seminar 1995. Portland, OR: American Tinnitus Association, 1995: 266-9.
128. Kemp DT. Cochlear echoes: Implication for noise-induced hearing loss. In: Hamernik RP, Henderson D, Salvi R (eds). New perspectives on noise-induced hearing loss. New York: Raven Press, 1982: 189-206.
129. Wegel RLA. A study of tinnitus. Archives of Otolaryngology - Head and Neck Surgery. 1931; 14: 160-5.
130. Wilson JP. Evidence for a cochlear origin for acoustic reemissions, threshold fine-structure and tonal tinnitus. Hearing Research. 1980; 2: 233-52.
131. Wilson JP, Sutton GJ. Acoustic correlates of tonal tinnitus. In: Evered D, Lawrenson G (eds). Tinnitus (CIBA Foundation Symposium). London: Pitman Books Ltd, 1981: 82-107.
132. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nature Neuroscience. 2002; 5: 1039-42.
133. Eybalin M. Neurotransmitters and neuromodulators of the mammalian cochlea. Physiological Reviews. 1993; 73: 309-73.
134. Puel JL. Chemical synaptic transmission in the cochlea. Progress in Neurobiology. 1995; 47: 449-76.
135. Pujol R. Lateral and medial efferents: A double neurochemical mechanism to protect and regulate inner and outer hair cell function in the cochlea. British Journal of Audiology. 1994; 28: 185-91.
136. Brix R, Denk DM, Ehrenberger K. Neurophysiological control in therapy of tinnitus with cochlear disorders. In: Reich GE, Vernon JA (eds). Proceedings of the V International Tinnitus Seminar 1995. Portland, OR: American Tinnitus Association, 1995: 101-5.
137. Denk DM, Heinzl H, Franz P, Ehrenberger K. Caroverine in tinnitus treatment. A placebo-controlled blind study. Acta Otolaryngologica. 1997; 117: 825-30.
138. Puel JL, Ruel J, Guitton M, Pujol R. The inner hair cell afferent/efferent synapses revisited: A basis for new therapeutic strategies. Advances in Otorhinolaryngology. 2002; 59: 124-30.
139. d'Aldin C, Eybalin M, Puel JL, Charachon G, Ladrech R, Renard N et al. Synaptic connections and putative functions of the dopaminergic innervation of the guinea pig cochlea. European Archives of Otorhinolaryngology. 1995; 252: 270-4.
140. Sahley TL, Nodar RH, Musiek FE. Endogenous dynorphins: Possible role in peripheral tinnitus. International Tinnitus Journal. 1999; 5: 76-91.
141. Eggermont JJ. Physiological mechanisms and neural models. In: Tyler R (ed.). Tinnitus handbook. San Diego: Singular, 2000: 85-122.
142. Sziklai I. The significance of the calcium signal in the outer hair cells and its possible role in tinnitus of cochlear origin. European Archives of Otorhinolaryngology. 2004; 261: 517-25.
143. 11 antagonist, reverses the negative summating potential recorded from the guinea pig cochlea. Hearing Research. 1990; 46: 277-88.
144. Espir M, Illingworth R, Ceranic B, Luxon LM. Paroxysmal tinnitus due to meningeoma in the cerebellopontine angle. Journal of Neurology, Neurosurgery and Psychiatry. 1997; 62: 401-3.
145. Milicic D, Alc-ada M. A tinnitus objectivization: How we do it. International Tinnitus Journal. 1999; 5: 5-15.
146. Cacace AT. Expanding the biological basis of tinnitus: Crossmodal origins and the role of neuroplasticity. Hearing Research. 2003; 175: 112-32.
147. Møller AR. Symptoms and signs caused by neural plasticity. Neurological Research. 2001; 23: 565-72.
148. Møller AR, Møller MB, Yokota M. Some forms of tinnitus may involve the extralemniscal auditory pathway. Laryngoscope. 1992; 102: 1165-71.
149. Cacace AT, Lovely TJ, McFarland DJ, Parnes SM, Winter DF. Anomalous cross-modal plasticity following posterior fossa surgery: Some speculations on gaze-evoked tinnitus. Hearing Research. 1994; 81: 22-32.
150. Rasmussen G. The olivary peduncle and other fibre projections of the superior olivary complex. Journal of Comparative Neurology. 1946; 84: 141-219.
151. Suga N, Gao E, Zhang Y, Ma X, Olsen JF. The corticofugal system for hearing: recent progress. Proceedings of the National Academy of Sciences of the USA. 2000; 97: 11807-14.
152. Collet L, Kemp DT, Veuillet E, Duclaux R, Moulin A, Morgon A. Effect of contralateral auditory stimuli on active cochlear micromechanical properties in human subjects. Hearing Research. 1990; 43: 251-62.
153. Veuillet E, Collet L, Disant F, Morgon A. Tinnitus and medial cochlear efferent system. In: Aran JM, Dauman R (eds). Tinnitus 91. Proceedings of the IV International Tinnitus Seminar, Bordeaux. Amsterdam/New York: Kugler Publications, 1992: 205-9.
154. Chery-Croze S, Moulin A, Collet L, Morgon A. Is the test of medial efferent system function a relevant investigation in tinnitus? British Journal of Audiology. 1994; 28: 13-25.
155. Ceranic B, Prasher DK, Raglan E, Luxon LM. Tinnitus following head injury: Evidence from otoacoustic emissions. Journal of Neurology, Neurosurgery and Psychiatry. 1998; 65: 523-9.
156. Graham RL, Hazell JW. Contralateral suppression of transient evoked otoacoustic emissions: Intra-individual variability in tinnitus and normal subjects. British Journal of Audiology. 1994; 28: 235-45.
157. Ceranic B, Prasher DK, Luxon LM. Presence of tinnitus indicated by variable spontaneous otoacoustic emissions. Audiology and Neuro-otology. 1998; 3: 332-44.
158. Attias J, Furman V, Shemesh Z, Bresloff I. Impaired brain processing in noise-induced tinnitus patients as measured by auditory and event-related potentials. Ear and Hearing. 1996; 17: 327-33.
159. Maison SF, Luebke AE, Liberman MC, Zuo J. Efferent protection from acoustic injury is mediated via alpha9 nicotinic acetylcholine receptors on outer hair cells. Journal of Neuroscience. 2002; 15: 10838-46.
160. Caspary DM, Salvi RJ, Helfert RH, Brozoski TJ, Bauer CA. Neuropharmacology of noise iduced hearing loss in brainstem auditory structures. In: Henderson D, Prasher D, Kopke R, Salvi R, Hamernik R (eds). Noise induced hearing loss: Basic mechanisms, prevention and control. London: Noise Research Network Publications, 2001: 169-83.
161. Bauer CA, Brozoski TJ, Holder TM, Caspary DM. Effects of chronic salicylate on GABAergic activity in rat inferior colliculus. Hearing Research. 2000; 147: 175-83.
162. Wang J, Ding D, Salvi RJ. Functional reorganisation in chinchilla inferior colliculus associated with chronic and acute cochlear changes. Hearing Research. 2002; 168: 238-49.
163. Salvi RJ, Hamernik RP, Henderson D. Discharge patterns in the cochlear nucleus of the chinchilla following noise induced asymptotic threshold shift. Experimental Brain Research. 1978; 32: 301-20.
164. Willot JF, Lu S-V. Noise-induced hearing loss can alter neural coding and increase excitability in the central nervous system. Science. 1982; 216: 1331-2.
165. Salvi RJ, Ahroon WA. Tinnitus and neural activity. Journal of Speech and Hearing Research. 1983; 26: 629-32.
166. Zacharek MA, Kaltenbach JA, Mathog TA, Zhang J. Effects of cochlear ablation on noise induced hyperactivity in the hamster dorsal cochlear nucleus: implication for the origin of noise induced tinnitus. Hearing Research. 2002; 172: 137-44.
167. Gerken GM. Central denervation hypersensitivity in the auditory system of the cat. Journal of the Acoustical Society of America. 1979; 66: 721-7.
168. Komiya H, Eggermont JJ. Spontaneous firing activity of cortical neurons in adult cats with reorganised tonotopic map following pure-tone trauma. Acta Otolaryngologica. 2000; 120: 750-6.
169. Chang H, Chen K, Kaltenbach JA, Zhang J, Godfrey DA. Effects of acoustic trauma on dorsal cochlear nucleus neuron activity in slices. Hearing Research. 2002; 164: 59-68.
170. Liberman MC, Kiang NYS. Acoustic trauma in cats. Cochlear pathology and auditory nerve activity. Acta Otolaryngologica. 1978; Suppl 358: 1-63.
171. Evans EF, Borerwe TA. Ototoxic effects of salicylates on the responses of single cochlear nerve fibres and on cochlear potentials. British Journal of Audiology. 1982; 16: 101-8.
172. Chen G, Jastreboff PJ. Salicylate-induced abnormal activity in the inferior colliculus of rats. Hearing Research. 1995; 82: 158-78.
173. Ochi K, Eggermont JJ. Effects of salicylate on neural activity in cat primary auditory cortex. Hearing Research. 1996; 95: 63-76.
174. Ochi K, Eggermont JJ. Effects of quinine on neural activity in cat primary auditory cortex. Hearing Research. 1997; 105: 105-18.
175. Robertson D, Irvine DRF. Plasticity of frequency organisation in auditory cortex of guinea pigs with partial unilateral deafness. Journal of Comparative Neurology. 1989; 282: 456-71.
176. Rajan R, Irvine DRF, Calford MB, Wise LZ. Effects of frequency-specific losses in cochlear neural activity on the processing and representation of frequency in primary auditory cortex. In: Dancer AL, Henderson D, Salvi RJ, Hamernik RP (eds). Noise induced hearing loss. St. Louis: Mosby Year Book, 1992: 119-29.
177. Schwaber MK, Garraghty PE, Kaas JH. Neuroplasticity of the adult primate auditory cortex following cochlear and hearing loss. American Journal of Otology. 1993; 14: 252-8.
178. MUhlnickel W, Elbert T, Taub E, Flor H. Reorganisation of auditory cortex in tinnitus. Proceedings of the National Academy of Sciences of the USA. 1998; 95: 10340-3.
179. Cransac H, Peyrin L, Cottet-Emard JM, Farhat E, Pequignot JM, Reber A. Aging effects on monoamines in rat medial vestibular and cochlear nuclei. Hearing Research. 1996; 100: 150-6.
180. Liu J, Li X, Wang L, Dong Y, Han H, Liu G. Effects of salicylate on serotoninergic activities in rat inferior collicuclus and auditory cortex. Hearing Research. 2003; 175: 45-53.
181. Salvi RJ, Lockwood AH, Burkard R. Neural plasticity and tinnitus. In: Tyler R (ed.). Tinnitus handbook. San Diego: Singular, 2000: 123-48.
182. Recanzone GH, Schreiner CE, Merzenich MM. Plasticity in the frequency representation of primary auditory cortex following discrimination training in adult owl monkeys. Journal of Neuroscience. 1993; 13: 87-103.
183. Lundberg U. Coping with stress: Neuroendocrine reactions and implications on health. Noise and Health. 1999; 1: 67-74.
184. Holgers KM, Erlandsson SI, Barrenas MI. Predictive factors for the severity of tinnitus. Audiology. 2000; 39: 284-91.
185. Erlandsson SI, Hallberg LR. Prediction of quality of life in patients with tinnitus. British Journal of Audiology. 2000; 34: 11-20.
186. Hébert S, Paiement P, Lupien SJ. A physiological correlate for the intolerance to both internal and external sounds. Hearing Research. 2004; 190: 1-9.
187. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiological Reviews. 1992; 72: 165-229.
188. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide physiology, pathophysiology and pharmacology. Pharmacological Reviews. 1991; 43: 109-41.
189. Kendel ER, Abrams T, Bernier L, Carew TJ, Hawkins RD, Schwartz JH. Classical conditioning and sensitisation show aspects of the same molecular cascade in aplysia. Cold Spring Harbor Symposia on Quantitative Biology. 1983; 48: 821-30.
190. Kendel ER. Cellular mechanisms of learning and biological basis of individuality. In: Kendel ER, Schwartz JH, Jessell TM (eds). Principles of neural science. New York: Elsevier, 1992: 1009-31.
191. Hughes RN. Cholinergic and monoaminergic substrates of startle habituation. Life Science. 1984; 34: 2101-5.
192. Geyer MA, Tapson GS. Habituation of tactile startle is alerted by drugs acting on serotonin-2 receptors. Neuropharmacology. 1988; 1: 135-47.
193. Walpurger V, Hebing-Lennartz G, Denecke H, Pietrowsky R. Habituation deficit in auditory event-related potentials in tinnitus complainers. Hearing Research. 2003; 181: 57-64.
194. Zöger S, Svedlund J, Holgers KM. Psychiatric disorders in tinnitus patients without severe hearing impairment: 24 month follow-up of patient at an audiology clinic. Audiology. 2001; 40: 133-40.
195. Harrop-Griffiths J, Katon W, Dobie R, Sakai C. Chronic tinnitus: Association with psychiatric diagnosis. Journal of Psychosomatic Research. 1987; 31: 613-21.
196. Hinchcliffe R, King P. Medicolegal aspects of tinnitus. I: Medicolegal position and current state of knowledge. Journal of Audiological Medicine. 1992; 1: 38-58.
197. Reich GE, Johnson RM. Personality characteristics of tinnitus patients. In: Schulman A (ed.). Proceedings of the II International Tinnitus Seminar. Journal of Laryngology and Otology (Suppl 9): 228-32.
198. Ressler KJ, Nemeroff CB. Role of epinephrine in the pathophysiology and treatment of mood disorders. Biological Psychiatry. 1999; 46: 1219-33.
199. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety. Depression and Anxiety. 2000; 12: 2-19.
200. Meyer JH, Kruger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A et al. Lower dopamine transporter binding potentials in striatum during depression. NeuroReport. 2001; 12: 4121-5.
201. Simpson JJ, Davies WE. A review of evidence in support of a role for 5-HT in the perception of tints. Hearing Research. 2000; 145: 1-7.
202. Gopal KV, Daly DM, Daniloff RG, Pennartz L. Effects of selective serotonin reuptake inhibitors on auditory processing: Case study. Journal of the American Academy of Audiologists. 2000; 11: 454-63.
203. Baguley DM, McFerran DJ. Tinnitus in childhood. International Journal of Pediatric Otorhinolaryngology. 1999; 49: 99-105.
204. Mills RP, Albert DM, Brain CE. Tinnitus in childhood. Clinical Otolaryngology. 1986; 11: 431-4.
205. Aust G. Tinnitus in childhood. International Tinnitus Journal. 2002; 8: 20-6.
206. Mills RP, Cherry JR. Subjective tinnitus in children with otological disorders. International Journal of Pediatric Otorhinolaryngology. 1984; 7: 21-7.
207. Martin K, Snashall S. Children presenting with tinnitus: A retrospective study. British Journal of Audiology. 1994; 28: 111-5.
208. Parnes LS, McCabe BF. Perilymph fistula: An important cause of deafness and dizziness in children. Paediatrics. 1987; 80: 524-8.
209. Telischi FF, Rodgers GK, Balkany TJ. Dizziness in childhood. In: Jackler RK, Brackmann DE (eds). Neurotology. New York: Mosby Year Book, 1994: 555-66.
210. Kentish RC, Crocker SR, McKenna L. Children's experience of tinnitus: Preliminary survey of children presenting to a psychology department. British Journal of Audiology. 2000; 34: 335-40.
211. Viani LG. Tinnitus in children with hearing loss. Journal of Laryngology and Otology. 1989; 103: 1142-5.
212. Rosanowski F, Hoppe U, Proschel U, Eysholdt U. Chronischer tinnitus bei kindern und jugendlichen. HNO. 1997; 45: 927-32.
213. Gabriels P. Children with tinnitus. In: Vernon JA, Reich GE (eds). Proceedings of the 5th International Tinnitus Seminar. Portland, OR: American Tinnitus Association, 1966: 270-4.
214. Shulman A, Strashun AM, Goldstein BA. GABAA -benzodiazepine-chloride receptor-targeted therapy for tinnitus control: Preliminary report. International Tinnitus Journal. 2002; 8: 30-6.
215. Kaczmarek JP, Szymiec E, Dabrowski P, Szyfter W. Unilateral tinnitus - diagnostics and treatment. Otolaryngologia Polska. 2002; 56: 361-4.
216. Sheppard IJ, Milford CA, Anslow P. MRI in the detection of acoustic neuromas: A suggested protocol for screening. Clinical Otolaryngology and Allied Sciences. 1996; 21: 301-4.
217. Fowler EP. Tinnitus aurium in the light of recent research. Annals of Otology, Rhinology, and Laryngology. 1941; 50: 139-58.
218. Tyler RS. The Psychoacoustical measurement of tinnitus. In: Tyler R (ed.). Tinnitus handbook. San Diego: Singular, 2000: 149-79.
219. Vernon JA, Meikle MB. Masking devices and alprazolam treatment for tinnitus. Otolaryngologic Clinics of North America. 2003; 36: 307-20.
220. Henry JA, Meikle MB. Psychoacoustic measures of tinnitus. Journal of the American Academy of Audiology. 2000; 11: 138-55.
221. Penner MJ. Variability in matches to subjective tinnitus. Journal of Speech and Hearing Research. 1983; 26: 263-7.
222. Feldmann H. Homolateral and contralateral masking of tinnitus by noise-bands and pure tones. Audiology. 1971; 10: 138-44.
223. Tyler RS, Conrad-Armes D. The determination of tinnitus loudness using loudness recruitment formulae. Journal of Speech and Hearing Research. 1983; 26: 59-72.
224. Tyler RS, Conrad-Armes D. Masking of tinnitus compared to masking of pure tones. Journal of Speech and Hearing Research. 1984; 27: 106-11.
225. Penner MJ. Audible and annoying spontaneous otoacoustic emissions. Archives of Otolaryngology, Head and Neck Surgery. 1988; 114: 150-3.
226. Penner MJ, Burns E. Dissociation of spontaneous acoustic emissions and tinnitus. Journal of Speech and Hearing Research. 1987; 30: 396-403.
227. Zwicker E. Masking in normal ears - psychoacoustical facts and physiological correlates. In: Feldmann H (ed.). Proceedings of the III International Tinnitus Seminar, Münster. Karlsruhe: Harsch Verlag, 1987: 214-23.
228. Tyler RS. The psychophysical measurement of tinnitus. In: Aran JM, Dauman R (eds). Tinnitus 91. Proceedings of the IV International Tinnitus Seminar, Bordeaux. Amsterdam/ New York: Kugler Publications, 1992: 17-26.
229. Attias J, Urbach D, Gold S, Shemesh Z. Auditory event related potentials in chronic tinnitus with noise induced hearing loss. Hearing Research. 1993; 71: 106-13.
230. Hoke ES, Muhlnickel W, Ross B, Hoke M. Tinnitus and event-related activity of the auditory cortex. Audiology and Neuro-otology. 1998; 3: 300-31.
231. Hoke M, Feldmann H, Pantev C, Lütkenhöner B, Lehnertz K. Objective evidence of tinnitus in auditory evoked magnetic fields. Hearing Research. 1989; 37: 281-6.
232. Shiomi Y, Nagamine T, Fujiki N, Hirano S, Naito Y, Shibasaki H et al. Tinnitus remission by lidocaine demonstrated by auditory evoked magnetoencephalogram. Acta Otolaryngologica. 1997; 117: 31-4.
233. Wilson PH, Henry JL. Psychological management of tinnitus. In: Tyler R (ed.). Tinnitus handbook. San Diego: Singular, 2000: 263-79.
234. Vernon J. Assessment of the patients with tinnitus. In: Hazell J (ed.). Tinnitus. Edinburgh: Churchill Livingstone, 1987: 71-95.
235. Dobie RA. A review of randomized clinical trial in tinnitus. Laryngoscope. 1999; 109: 1202-11.
236. Waddell A. Tinnitus. Clinical Evidence. 2004; 12: 798-807.
237. The Cochrane Library/Ear Nose Throat Disorders/Ear/Inner Ear/Tinnitus http://www.cochrane.org/reviews/en/topics/ 60.html (search September 2006).
238. Fowler EP, Fowler Jnr. EP. Somatopsyhcic and psychosomatic factors in tinnitus, deafness and vertigo. Annals of Otolaryngology. 1955; 64: 29-37.
239. Dobie RA, Sakai CS, Sullivan MD, Katon WJ, Russo J. Antidepressant treatment of tinnitus patients: Report of a randomized clinical trial and clinical prediction of benefit. American Journal of Otology. 1993; 14: 18-23.
240. Podoshin L, Ben-David Y, Fradis M, Malatskey S, Hafner H. Idiopathic subjective tinnitus treated by aminotriptyline hydrochloride/biofeedback. International Tinnitus Journal. 1995; 1: 54-60.
241. Shemen L. Fluoxetine for treatment of tinnitus. Otolaryngology and Head and Neck Surgery. 1998; 118: 421.
242. O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. Journal of Family Practice. 1999; 48: 980-90.
243. Folmer RL, Shi YB. SSRI use by tinnitus patients: Interaction between depression and tinnitus severity. Ear, Nose and Throat Journal. 2004; 83: 107-8.
244. Johnson RM, Brummett R, Schleuning A. Use of alprozolam for relieve of tinnitus: Double-blind study. Archives of Otolaryngology, Head and Neck Surgery. 1993; 119: 842-5.
245. Bumby AE, Stephens SDG. Clonazepam in the treatment of tinnitus - a pilot study. Journal of Audiological Medicine. 1997; 6: 98-104.
246. Gananca MM, Caovilla HH, Gananca FF, Gananca CF, da Silva LG, Lei Munhoz MS et al. Clonazepam in the pharmacological treatment of vertigo and tinnitus. International Tinnitus Journal. 2002; 8: 50-3.
247. Westerberg BD, Roberson Jr. JB, Stach BA. A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus. American Journal of Otology. 1996; 17: 896-905.
248. Theopold HM. Nimodipine: A new therapy concept in diseases of the inner ear. Laryngologie, Rhinologie, Otologie. 1985; 64: 609-13.
249. Davies E, Knox E, Donaldson I. The usefulness of nimodipine, an L-calcium chanel antagonist, in the treatment of tinnitus. British Journal of Audiology. 1994; 28: 125-9.
250. Shulman A. Neuroprotective drug therapy: A medical and pharmacological treatment for tinnitus. International Tinnitus Journal. 1997; 3: 77-93.
251. Hulshof JH, Vermij P. The value of flunarazine in the tratment of tinnitus. ORL Journal for Otorhinolaryngology and its Related Specialties. 1986; 48: 33-6.
252. Shea JJ, Harell M. Management of tinnitus aurium with lidocaine and carbamazepine. Laryngoscope. 1978; 88: 1477-84.
253. Melding PS, Goodey RJ. The treatment of tinnitus with oral anticonvulsants. Journal of Laryngology and Otology. 1979; 93: 111-22.
254. Menkes DB, Larson PM. Sodium valproate for tinnitus. Journal of Neurology, Neurosurgery and Psychiatry. 1998; 65: 803.
255. Davies WE, Weiner GM, Gilber AM, Simpson JJ. The assessment of lamotrigine, an anti-epileptic drug, in the treatment of tinnitus - a preliminary report. In: Reich GE, Vernon JA (eds). Proceedings of the Fifth International Tinnitus Seminar. Portland: American Tinnitus Association, 1995: 225-8.
256. Briner W, House J, O'Leary M. Synthetic prostaglandin E1 misoprostol as a treatment for tinnitus. Archives of Otolaryngology, Head and Neck Surgery. 1993; 119: 652-4.
257. Yilmaz I, Akkuzu B, Cakmak OO, OOzuloglu LN. Misoprostol in the treatment of tinnitus: A double-blind study. Otolaryngology and Head and Neck Surgery. 2004; 130: 604-10.
258. Martin FW, Colman BH. Tinnitus: A double-blind crossover controlled trial to evaluate the use of lignocaine. Clinical Otolaryngology. 1980; 5: 3-11.
259. Den Hartigh J, Hilders CG, Schoemaker JH, Hulshof JH, Cohen AF, Vermeij P. Tinnitus suppression by intravenous lidocaine in relation to its plasma concentration. Clinical Pharmacology and Therapeutics. 1993; 54: 415-20.
260. Baguley DM, Jones S, Wilkins I, Axon PR, Moffat DA. The inhibitory effect of intravenous lidocaine infusion on tinnitus after translabyrinthine removal of vestibular schwannoma: A double-blind, placebo-controlled, crossover study. Otology and Neurotology. 2005; 26: 169-76.
261. Andersson G, Lyttkens L. A meta-analytic review of psychological treatments for tinnitus. British Journal of Audiology. 1999; 33: 201-10.
262. Andersson G, Stromgren T, Strom L, Lyttkens L. Randomised controlled trial of internet-based cognitive behaviour therapy for distress associated with tinnitus. Psychosomatic Medicine. 2002; 64: 810-6.
263. Rubinstein JT, Tyler RS, Johnson A, Brown CJ. Electrical suppression of tinnitus with high-rate pulse trains. Otology and Neurotology. 2003; 24: 478-85.
264. Kleinjung T, Eichhammer P, Langguth B, Jacob P, Marienhagen J, Hajak G et al. Long-term effects of repetitive transcranial magnetic stimulation (rTMS) in patients with chronic tinnitus. Otolaryngology and Head and Neck Surgery. 2005; 132: 566-9.
265. Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW. The complete German commission E monographs: Therapeutic guide to herbal medicines. Austin, Texas: American Botanical Council, 1998.
266. Jastreboff PJ, Hazell JWP. A neurophysiological approach to tinnitus: Clinical implications. British Journal of Audiology. 1993; 27: 7-17.
267. Brooks DN, Bulmer D. Survey of binaural hearing aid users. Ear and Hearing. 1981; 2: 220-4.
268. Melin L, Scott B, Lindberg P, Lyttkens L. Hearing aids and tints - an experimental group study. British Journal of Audiology. 1987; 21: 91-7.
269. Ito J. Tinnitus suppression in cochlear implant patients. Otolaryngology and Head and Neck Surgery. 1997; 117: 701-3.
270. Ruckenstein MJ, Hedgepeth C, Rafter KO, Montes ML, Bigelow C. Tinnitus suppression in patients with cochlear implants. Otology and Neurotology. 2001; 22: 200-4.
271. Mo B, Harris S, Lindbœk M. Tinnitus in cochlear implant patients - a comparison with other hearing-impaired patients. International Journal of Audiology. 2002; 41: 527-34.
272. Vernon J. The history of masking as applied to tinnitus. Journal of Laryngology and Otology. 1981; 4: 76-9.
273. Holgers K-M, Barrenas M-L. The pathophysiology and assessment of tinnitus. In: Luxon L, Furman J, Martini A, Stephens SDG (eds). Textbook of Audiological Medicine. London: Martin Dunitz, 2003: 555-69.
274. McKenna L, Hallam RS, Hinchcliffe R. The prevalence of psychological disturbance in neuro-otology outpatients. Clinical Otology. 1991; 16: 452-6.
275. Jakes SC, Hallam RS, McKenna L. Group cognitive therapy for medical patients: An application to tinnitus. Cognitive Therapy and Research. 1992; 16: 67-82.
276. Cook S, Savage J, Waddell A. Clinical Evidence BMJ/Ear, Nose and Throat Disorders/Tinnitus. Available from http:// www.clinicalevidence.com/ceweb/conditions/ent/0506/ 0506.jsp.
277. Cruz OLM, Kasse CA, Sanchez M, Barbosa F. Serotinin reuptake inhibitors in auditory processing disorders in elderly patients: Preliminary results. Laryngoscope. 2004; 114: 1656-9.
278. Murai K, Tyler RS, Harker LA, Stouffer JL. Review of pharmacological treatment of tinnitus. American Journal of Otology. 1992; 13: 454-64.
279. Barany B. Die Beeinflussung des Ohrensausens durch intravenos injizierte Lokalaneasthesthetica. Acta Otolaryngologica. 1935; 23: 201-7.
280. Jackson P. Electrocochleographic findings and the effects of lidocaine on tinnitus in nonhearing ears. Journal of Laryngology and Otology. 1985; 99: 667-70.
281. Laurikainen EA, Johansson RK, Kileny PR. Effects of intratympanically delivered lidocaine on the auditory system in humans. Ear and Hearing. 1996; 17: 49-54.
282. Melcher JR, Sigalovski IS, Guinan Jr. JJ, Levine RA. Tinnitus-related fMRI. Activation patterns in human auditory nuclei. In: Hazell J (ed.). Proceedings of the Sixth International Tinnitus Seminar. London: The Tinnitus and Hyperacusis Centre, 1999: 166-70.
283. Condouris GA. Local anaesthetics as modulators of neural information. In: Bonica JJ, Albe-Fessard D (eds). Advances in pain research and therapy, Vol. 1. New York: Raven Press, 1976.
284. Sakata H, Kojima Y, Koyama S, Furuya N, Sakata E. Treatment of cochlear tinnitus with transtympanic infusion of 4% lidocaine into the tympanic cavity. International Tinnitus Journal. 2001; 7: 46-50.
285. Drew S, Davies E. Effectiveness of Ginkgo biloba in treating of tinnitus: Double blind, placebo-controlled trial. British Medical Journal. 2001; 322: 73.